News
Topics
J-Pharma’s LAT1 Inhibitor JPH034 Initiates Phase 1 Clinical Trial in the United States – Axcelead DDP Supported Multiple IND-Enabling Studies –
J-Pharma Co., Ltd. (“J-Pharma”) has announced that dosing of the first subject has commenced in the Phase...
Co-authored Paper by Researcher Matsumoto and Researcher Miura of the Translational Research Business Unit Published in Gut Pathogens
Cross-organ multi-omics profiling of microbiome and metabolome along the gut-liver axis in MASH model mice induced by...
Researcher Yamamoto from Pharmacology Business Unit to Present a Poster at the World Congress of Nephrology 2026
Researcher Yamamoto from Pharmacology Business Unit, will deliver a poster presentation at The World Congress of Nephrology...
Researcher Hashikami from Pharmacology Business Unit to Present a Poster at the World Congress of Nephrology 2026
Researcher Hashikami from Pharmacology Business Unit , will deliver a poster presentation at The World Congress of...
A co-authored paper by researcher Miura of the DMPK & Safety Business Unit was published in Metabolites
Investigation of storage conditions and quality control markers for metabolites and lipids in human feces Publication Published...